KLK3 and cancer: Previous studies have found that mitochondrial mutations are associated with increased serum prostate-specific antigen (PSA) levels21, have suggested that mtDNA mutations increase cancer cell tumorigenicity20, and indicate that overall mitochondrial mutation burden is correlated with higher Gleason Scores22.